Insider trades

Chris Degnan, CFO of UroGen Pharma URGN, has filed 1 purchase and 1 sale on the open market. Over the past 12 months that comes to a net sale of $37.1K. The latest trade was on 01/31.

Chris Degnan

CFO
First filing
23/02/28
Trades
8 trades
Buys / sales
1 / 1
12-month net buying
−$37.1K
Last trade
01/31

Trading activity

Transactions

Trade type
Open-market sale25/10/0825/10/092,203 sh$16.85$37,120.55−49.1%
Open-market buy23/03/1323/03/1410,000 sh$1.96$19,600No record